Effect of recombinant growth hormone and chromium picolinate on cytokine production and growth performance in swine

Pathobiology

Volumn 63, Issue 5, 1995, Pages 283-287

  Myers, Michael J ^a   Farrell, Dorothy E ^a   Evock Clover, Christina M ^b   Cope, Carol V ^a   Henderson, Mark ^a   Steele, Norman C ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Chromium picolinate; Cytokine production; Growth hormone; Porcine; Recombinant

Indexed keywords

CHROMIUM PICOLINATE; CYTOKINE; ENDOTOXIN; GROWTH HORMONE; INTERLEUKIN 2; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; RECOMBINANT GROWTH HORMONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BODY GROWTH; BODY WEIGHT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; GLUCOSE BLOOD LEVEL; MONONUCLEAR CELL; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SWINE;

ANIMALS; BODY COMPOSITION; BODY WEIGHT; CYTOKINES; DIET; GROWTH HORMONE; IRON CHELATING AGENTS; PICOLINIC ACIDS; RECOMBINANT PROTEINS; SWINE;

EID: 0029552975     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000163962     Document Type: Article

References (34)

1. Kelley KW: Growth hormone, lymphocytes and macrophages. Biochcm Pharmacol 1989; 38: 705-713.
2. Kenison DC, Elsasser TH, Fayer R: Tumor necrosis factor alpha as a potential mediator of metabolic and hormonal responses to endotox-cmia in calves. Am J Vet Res 1991: 52: 1320-1326.
3. Bateman A. Singh A, Krai T, Solomon S: The immune-hypothalamic-pituitary-adrenal axis. Endocr Rev 1989; 10: 92-112.
4. Milenkivic L, Rettori V, Snyder GD, Beutler B. McCann S: Cachectin alters pituitary hormone release by a direct action in vitro. Proc Natl Acad Sci 1989; 8: 2418-2422.
5. Elsasser TH, Capema TJ, Fayer R: Tumor necrosis factor alpha affects growth hormone secretion by a direct pituitary interaction. Proc Soc Exp Biol Med 1991; 198: 547-554.
6. Evock-Clover CM, Polansky MM, Anderson RA. Steele NC: Dietary chromium supplementation with or without somatotropin treatment alters serum hormones and metabolites in growing pigs without affecting growth performance. J Nutr 1993; 123: 1504-1512.
7. Evock CM, Etherton TD, Chung CS, Ivy RE: Pituitary porcine growth hormone (pGH) and a recombinant pGH analog stimulate pig growth performance in a similar manner. J Anim Sci 1988, 66: 128.
8. Etherton TD, Wiggins JP, Evock CM, Chung CS, Rebhun JF. Walton PE, Steele NC: Stimulation of pig growth performance by porcine growth hormone: Determination of the dose-response relationship. J Anim Sci 1987: 64: 433-443.
9. Evock CM, Capema TJ, Steele NC, McMurtry JP. Rosebrough RW: Influence of time of injection of recombinant porcine somatotropin (rPST) relative to time of feeding on growth performance, hormone and metabolite status, and muscle RNA, DNA and protein in pigs. J Anim Sci 1991: 69: 2443-2451.
10. Page TG, Southern LL, Ward TL, Thompson DL Jr: Effect of chromium picolinate on growth and serum and carcass traits of growing-finishing pigs. J Anim Sci 1993; 71: 656-662.
11. Mertz W: Chromium in human nutrition: A review. J Nutr 1993; 123: 626-633.
12. Burton JL. Mallard BA, Mowat DH: Effects of supplemental chromium on response of newly weaned beef calves to IBR/IP3 vaccination. Can J Vet Res 1994; 58: 148-151.
13. Elvinger F. Hansen PJ, Head HH, Natzke RP: Action of bovine somatotropin on polymorphonuclear leukocytes and lymphocytes in cattle. J Dairy Sci 1991. 74: 2145-2152.
14. Schimpf RM, Repellin AM: In vitro effect of human growth hormone on lymphocyte transformation and lymphocyte growth factor secretion. Acta Endocrinol 1989: 120: 745-752.
15. Burton JL, McBride BW, Kennedy BW. Burton JH. Elsasser TH, Woodward B: Influence of exogenous bovine somatotropin on the responsiveness of peripheral blood lymphocytes to mitogen J Dairy Sci 1991; 74: 916-928.
16. Edwards CK III. Ghiasuddin SM. Schepper JM. Yunger LM, Kelley KW: A newly defined property of somatotropin: Priming of macrophages for production of superoxide anion. Science 1988; 239: 769-771.
17. Fu Y-K. Arkins S, Li YM, Dantzer R, Kelley KW: Reduction in superoxide anion secretion and bacterial activity of neutrophils from aged rats: Reversal by the combination of gamma interferon and growth hormone. Infect Immun 1994; 62: 1-8.
18. Hooge R, Delhase M, Vergane P, Malur A, Hooge-Peters EL: Growth hormone and prolactin are paracrine growth and differentiation factors in the haemopoietic system. Immunol Today 1993; 14: 212-214.
19. Burton JL, McBride BW, Kennedy BW, Burton JH, Elsasser TH. Woodward B: Hematological profiles in dairy cows treated with recombinant bovine somatotropin. J Anim Sci 1992; 70: 1488-1495.
20. Elsasser TH. Fayer R, Rumsey TS. Hartnell GF: Recombinant bovine somatotropin blunts plasma tumor necrosis factor-alpha, cortisol, and thromboxane-B2 responses to endotoxin in vivo. Endocrinology 1994; 134: 1082-1088.
21. Ppsilac Freedom of Information Summary. 1993, pp 87-93.
22. Burton JL, McBride BW, Kennedy BW. Burton JH. Elsasser TH. Woodward B: Serum immunoglobulin profiles of dairy cows chronically treated with recombinant bovine somatotropin. J Dairy Sci 1991; 74: 1589-1598.
23. Burton JL, McBride BW, Kennedy BW, Burton JH, Elsasser TH, Woodward B: Contact sensitivity and systemic antibody responses in dairy cows treated with recombinant bovine somatotropin. J Dairy Sci 1992; 75: 747-755.
24. Goff BL, Flaming KP, Frank DE, Roth JA: Recombinant porcine somatotropin: An immunological study. J Anim Sci 1991: 69: 4523-4537.
25. Myers MJ. Blanton RH, Bick PH: Inhibition of IL-2 responsiveness following exposure to ben-zo(a)pyrene is due to alterations in accessory cell functionality. Int J Immunopharmacol 1988; 10: 177-186.
26. Schook LB, Lockwood JF, Yang S-D, Myers MJ: Dimcthylnitrosamine (DMN)-induced IL-lβ, TNF-α and IL-6 inflammatory cytokine gene expression. Toxicol Appl Pharmacol 1992: 116: 110-116.
27. Baarcsh MJ, Wannaamuehler MJ, Molitor TW, Murtaugh MP: Detection of tumor necrosis factor α from alveolar macrophages using an L929 fibroblast assay. J Immunol Methods 1991; 140: 15-22.
28. Waage A. Brandtzaeg P, Halstensen A, Kierulf P. Espevik T: The complex pattern of cytokines in serum from patients with meningococcal septic shock. N Engl J Med 1989; 169: 333-338.
29. Michie HR, Manogue KR, Spriggs DR, et al: Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1985; 318: 1481-1486.
30. Beutler BA. Milsark IW, Cerami A: Cachectin/tumor necrosis factor: Production, distribution and metabolic fate in vivo. J Immunol 1985; 135: 3972-3977.
31. Flick DA, Gifford GE: Production of tumor necrosis factor in unprimed mice: Mechanism endotoxin-mediated necrosis. Immunobiology 1986; 171: 320-328.
32. Waage A: Production and clearance of tumor necrosis in rats exposed to endotoxin and dexa-methasone. Clin Immunol Immunopathol 1987; 45: 348-355.
33. Waage A. Halstensen A, Shalaby R. Brandtzaeg P. Kierulf P. Espevik T: Local production of tumor necrosis factor, interleukin 1, and interleukin 6 in meningococcal meningitis. J Exp Med 1989; 170: 1859-1867.
34. Shalaby R. Waage A, Aarden L, Espevik T: Endotoxin, tumor necrosis factor-alpha/cachectin and interleukin 1 induce interleukin 6. production in vivo. Clin Immunol Immunopathol 1989; 53: 488-498.